ZENA Valuation
ZenaTech Inc
$
2.200
- Overview
- Forecast
- Valuation
ZENA Relative Valuation
ZENA's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ZENA is overvalued; if below, it's undervalued.
Historical Valuation
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
-2.48
P/B
Median3y
8.01
Median5y
8.01
-13.82
FCF Yield
Median3y
-5.94
Median5y
-5.94
Competitors Valuation Multiple
The average P/S ratio for ZENA's competitors is 1.67, providing a benchmark for relative valuation. ZenaTech Inc Corp (ZENA) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of -4.40%, this premium appears unsustainable.
People Also Watch
MREO
Mereo BioPharma Group PLC
2.600
USD
+0.39%
FC
Franklin Covey Co
20.590
USD
+1.38%
KROS
Keros Therapeutics Inc
14.570
USD
+0.90%
PNNT
Pennantpark Investment Corp
6.410
USD
-1.69%
AKBA
Akebia Therapeutics Inc
2.390
USD
-0.83%
GCO
Genesco Inc
19.480
USD
+0.41%
AAM
AA Mission Acquisition Corp
10.320
USD
+0.10%
EQV
EQV Ventures Acquisition Corp
10.200
USD
+0.20%
CVRX
CVRx Inc
7.290
USD
-0.41%
TCBX
Third Coast Bancshares Inc
30.310
USD
+1.71%
FAQ
Is ZenaTech Inc (ZENA) currently overvalued or undervalued?
ZenaTech Inc (ZENA) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of ZenaTech Inc (ZENA) is between to according to relative valuation methord.
What is ZenaTech Inc (ZENA) fair value?
How does ZENA's valuation metrics compare to the industry average?
What is the current P/B ratio for ZenaTech Inc (ZENA) as of May 02 2025?
What is the current FCF Yield for ZenaTech Inc (ZENA) as of May 02 2025?
What is the current Forward P/E ratio for ZenaTech Inc (ZENA) as of May 02 2025?